Vesalius Cardiovascular completes animal study of percutaneous mitral regurgitation device

Vesalius Cardiovascular has announced the successful completion of its first 30-day chronic animal study using its mitral valve repair device. The predetermined endpoints of the study were the absence of device or valve thrombosis and the absence of leaflet injury due to the device, and both endpoints were robustly confirmed upon completion of the [...]